---
id: '1OzDs__SEnsAFmh1GuwxLwWJLq64KIdpXDe_bG5b1OPE'
title: 'Redirect to: CMS 135 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)'
date: '2023-11-16T18:10:40.330Z'
source: 'https://drive.google.com/open?id=1OzDs__SEnsAFmh1GuwxLwWJLq64KIdpXDe_bG5b1OPE'
mimeType: 'text/x-markdown'
url: '../quality-measure-specifications-and-recommended-workflows/cms-135-heart-failure-hf-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy-for-left-ventricular-systolic-dysfunction-lvsd.md'
redirectTo: '1OzDs__SEnsAFmh1GuwxLwWJLq64KIdpXDe_bG5b1OPE'
autogenerated: true
wikigdrive: '1f3be24cb6d0e684833cf8ee6161c6af8024a3bd'
---
Renamed to: [CMS 135 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)](../quality-measure-specifications-and-recommended-workflows/cms-135-heart-failure-hf-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy-for-left-ventricular-systolic-dysfunction-lvsd.md)
